There is considerable evidence from case-control studies that a low serum level of vitamin A is an important risk factor for the development of a variety of human cancers of epithelial cell origin [1] [2] [3] [4] [5] [6] [7] [8] . Several of these studies [1, [4] [5] [6] , 8J have aiso indicated that the presence of an established cancer is associated with low serum concentrations of the vitamin A transport proteins, which include retinol-binding protein (RBP) and prealbumin. Furthermore, in our recent study [9] where serum vitamin A and RBP levels were measured in patients with surgical1y resected cancers of the colon and rectum, those who subsequently had recurrent disease showed lower levels of vitamin A and RBP compared with those who remained free of recurrence. Low RBP levels in plasma have also been reported in patients with recurrence of breast tumors, when compared with the "To whom correspondence should be addressed. No significant differences due to sex were found in the median assay values fOT vitamin A, RBP, or prealbumin in any of the three groups of subjects. However, in the group as a whole, prealbumin was higher in males an this achieved marginal significance (p<O.05). The Spearman rank correlations showed that age is not significantly correlated with assay values in any of the three groups of subjects. In the groups combined, prealbumin was significantly correlated with age (r= -0.22; p < 0.02).
The values for the three study parameters in the three groups of subjects are Table 2 . Serum vitamin A, R BP, and prealbumin j n patients with colorectal cancer or benign colorectal disease and in healthy subjects. shown in Table 2 . Pair-wise comparisons showed that for each study parameter, values for colorectal cancer subjects were significantly lower than those for healthy subjects but were not significantly different from those for the subjects with benign colorectal disease. The correlations between assay measurements were found to be highly significant (Table 3) .
DISCUSSlON
There have been many case-control studies showing an inverse relationship between cancer incidence and serum concentrations of vitamin A [6, 8, 9, 15, 16 ]. AU of these studjes have shown subnormal levels of serum vitamin A in cancer patients compared with the levels of healthy subjects or patients with unspecified
Vo1. 10, No.1,non-malignant disease. These findings are similar to the results obtained in the present study. Not only the serum levels of vitamin A but also of its transport proteins (RBP and prealbumin) were significantly lower in patients with colorectal cancer than in age-and sex-matched healthy subjects. However, no significant differences were apparent when the colorectal cancer patients were compared with a different control group, namely, subjects with benjgn coJorectal disease. These results indicate thm depressed levels of the three study parameters are a feature of a diseased state and are not specific to cancer. The results therefore provide no evidence that abnormalities of vitamin A status are directly related to cancer (c.g., by being a precursor or a consequence).
Vitamin A in the serum was measured by the fluorometric procedure of Hansen and 'Warwick [13J, which has been reported to measure not only vitamin A hut also phytofl uene, a non-vitamin A component [17] . Hence, it may be argued that the validity of the conclusions based on the serum vitamin A levels is questionable.
It should, however, be pointed out that serum vitamin A determined in this study was highly correlated with RBP and prealbumin. Thus values derived by simple fluorometry do, at least in part, reflect serum vitamin A. Furthermore, measurement of senlm vitamin A alone, even by the most specific method, provides little information on the cause of the low levels because serum vitamin A concentrations are nOT generally strongly influenced by dietary vitamin A intake [18J. It is noteworthy rhat the results of the present study resemble a similar study carried out on breast cancer [19] . In that study also cancer patients had lower serum values for the three parameters sludied here but the magnitude of the differences were reduced when the cancer patients were compared with patients suffering from benign breast disease. 
